Free Trial

Vertex Pharmaceuticals (VRTX) SEC Filings & 10K Form

$464.92
-12.98 (-2.72%)
(As of 09/20/2024 ET)

Recent Vertex Pharmaceuticals SEC Filings

DateFilerForm TypeView
08/30/2024
3:47 PM
Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:23 PM
LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
3:08 PM
Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
10:47 AM
Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
8:52 AM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
3:17 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
2:34 PM
SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2024
2:25 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
3:06 PM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
3:05 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
11:27 AM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/22/2024
12:16 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
9:27 AM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2024
9:23 AM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2024
3:09 PM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:11 PM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
8:54 AM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2024
8:56 AM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2024
3:11 PM
Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:09 PM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
12:56 PM
Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
12:38 PM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
9:50 AM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2024
10:48 AM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
3:08 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
9:05 AM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2024
9:51 AM
Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2024
12:13 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2024
3:21 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
12:45 PM
SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2024
2:32 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2024
7:36 AM
Vertex Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
7:25 AM
ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
Form SC TO-T/A
05/15/2024
11:20 AM
Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2024
10:41 AM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2024
10:50 AM
Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/10/2024
7:01 AM
ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
Form SC TO-T/A
05/08/2024
7:54 AM
ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
Form SC TO-T/A
05/03/2024
3:05 PM
Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
9:07 AM
Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/22/2024
3:15 PM
ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
Form SC TO-T
Sell NVDA Now? (Ad)

Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.

Now he's just issued a warning for the most popular stock in the world: Nvidia (NVDA).
04/16/2024
3:56 PM
Arjuna Capital (Filed by)
Vertex Pharmaceuticals (Subject)
Form PX14A6G
04/11/2024
3:08 PM
ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
Form SC TO-C
04/11/2024
6:13 AM
Vertex Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
6:17 AM
Vertex Pharmaceuticals (Subject)
Form SC TO-C
04/10/2024
4:22 PM
ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
Form SC TO-C
04/10/2024
11:14 AM
Capital World Investors (Filed by)
Vertex Pharmaceuticals (Subject)
Form SC 13G/A
04/04/2024
3:05 PM
Vertex Pharmaceuticals (Filer)
Form ARS
02/27/2024
3:44 PM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
3:37 PM
Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
3:24 PM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
12:19 PM
Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
10:25 AM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
10:10 AM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
9:44 AM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
9:52 AM
Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
9:26 AM
Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/23/2024
3:28 PM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:16 PM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:43 PM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:49 PM
Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:38 PM
Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:26 PM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:29 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
10:38 AM
Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
9:44 AM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
9:52 AM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
9:16 AM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
8:50 AM
Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
8:43 AM
Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
10:03 AM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
10:29 AM
Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
9:57 AM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
9:32 AM
Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
9:22 AM
Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
9:22 AM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/15/2024
10:19 AM
LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
4:11 PM
Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2024
4:34 PM
Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
4:23 PM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
12:42 PM
Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
12:24 PM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
11:44 AM
Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
10:32 AM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
9:32 AM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
8:52 AM
Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2024
5:19 PM
Capital World Investors (Filed by)
Vertex Pharmaceuticals (Subject)
Form SC 13G/A
02/09/2024
9:05 AM
FMR LLC (Filed by)
Vertex Pharmaceuticals (Subject)
Form SC 13G/A
02/08/2024
3:38 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
3:40 PM
LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
3:43 PM
Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
War on Elon Escalates… (Ad)

Elon Musk, the guy slated to become the world’s first trillionaire by 2027, has publicly called for the adoption of this technology for decades. By doing so he has put himself in the crosshairs of an ideological war with the global elites. And yet, while this new technology threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

Click here to learn how you can benefit from its widespread distribution.
02/08/2024
3:45 PM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
3:47 PM
Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
3:20 PM
Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
3:10 PM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
3:09 PM
Vertex Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
3:06 PM
LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:56 PM
LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
3:17 PM
Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
9:32 AM
Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VRTX) was last updated on 9/22/2024 by MarketBeat.com Staff
From Our Partners